The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
To guide prevention efforts for fatal poisonings in pediatric patients, the authors of a recent study examined characteristics of death from poisoning in young children within the United States.
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
Researchers examined the implementation of a restricted opioid prescribing plan for patients who experienced pain post-surgery in efforts to reduce chronic opioid use.
The researchers examined trends in opioid prescribing in the United States as professional organizations update their pain management guidelines to reduce opioid use.
In a recent study, researchers compared the efficacy of a mindfulness-based treatment vs group psychotherapy for patients with chronic pain and misusing opioids.
